Data / Form D filings / Syncromune, Inc.
Syncromune, Inc.: Form D filings
Syncromune, Inc., a biotechnology company in Fort Lauderdale, FL, filed 5 Form D notices with the SEC between 2022 and 2026. The latest, on May 11, 2026, reports $144.8 million sold of a $144.8 million offering to 77 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2919 E. COMMERCIAL BLVD., SUITE 200, Fort Lauderdale, FL, 33308
- Phone
- (518) 796-6110
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1955312
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | Amendment | $144,828,791 | $144,828,791 | 77 | Dec 3, 2024 | sec.gov | |
| Aug 21, 2025 | Amendment | $144,828,791 | $111,828,793 | $32,999,998 | 77 | Dec 3, 2024 | sec.gov |
| Dec 17, 2024 | New notice | $144,828,883 | $50,828,889 | $93,999,994 | 78 | Dec 3, 2024 | sec.gov |
| Oct 6, 2023 | Amendment | $20,000,000 | $14,180,000 | $5,820,000 | 44 | May 18, 2022 | sec.gov |
| Nov 29, 2022 | New notice | $20,000,000 | $5,310,000 | $14,690,000 | 16 | May 18, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles J. Link | Executive Officer, Director | |
| Eamonn Hobbs | Executive Officer, Director | |
| Joseph Gerardi | Executive Officer | |
| Agustin Gago | Executive Officer | |
| Joseph C. Maroon | Director | |
| Douglas G. Watson | Director | |
| Jeffrey L. Cleland | Director | |
| Norman Schwartz | Director | |
| Kerri-Ann Millar | Executive Officer | |
| Stephen Dale | Executive Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of May 11, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Syncromune, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.